CD38 and rheumatoid arthritis: Wang et al. proposed that a high percentage of CD38+ NK cells and a low percentage of CD38+ NK-like T cells in RA disrupt immune tolerance by stimulating mTOR signaling in CD4+ T cells and inhibiting the differentiation of regulatory T cells [60].